Pharma - Industry – Focus

 

Custom Search

Bulk Drug Manufacturing

Patel Pharmachem plans bulk drug unit at Sanand

Patel Pharmachem Pvt Ltd plans bulk drug unit at Ivaya in Sanand in Ahmedabad district of Gujarat with an investment of Rs. 8.5 million. The project involves setting up of manufacturing facilities to produce Valproic Acid (Dipropylacetic acid), Calcium Valproate (Calcium Dipropylacetate Hydrate), Magnesium Valproate (Magnesium Dipropylacetate Hydrate, Sodium Valproate (Sodium Dipropylacetate Hydrate, Divalproex Sodium, Phenyl Butazone and by-products like Ethanol and Sodium Acetate. The total production capacity of the plant will be 30 mtpm.

Apothecon Pharmaceuticals plans bulk drug unit at Dadhasa

Apothecon Pharmaceuticals Ltd plans bulk drug unit at Dadhasa in Jambusar in Padra in Gujarat with an investment of Rs. 400 million. The unit will require hazardous raw materials like Toluene, Methanol, Acetone, Dichloromethane, Hexane, Ethyl acetate, Isopropyl alcohol, Ethanol, Butanol etc. The project involves setting up of manufacturing facilities to produce Colesevelam ( 20 mtpm), Aztreonam( 2mptm), Felbamate ( 6 mtpm), Fomepizole (1 mtpm), Iron sucrose complex ( 5 mtpm) and other chemicals. The unit will have a total production capacity of 79.75 mtpm. The plant will also produce by-products like sodium chloride and ammonium chloride.

Suril Pharma plans expansion of bulk drug unit at Ankleshwar

Suril Pharma plans expansion of bulk drug unit at Ankleshwar in Bharuch district in Gujarat with an investment of Rs. 13 million. The project involves expanding manufacturing facilities to produce Omeprazole, Glibenclamide, Mebendazole (17.5 mtpm) and by-products from Omeprazole (Chloro Methane, Sodium Nitrite, Hydrochloric Acid and Sodium Bi Sulphate). The expansion will be carried out at its existing premises.

Ajanta Pharma to set up active pharmaceutical ingredients (API) unit at Waluj

Ajanta Pharma Ltd to set up active pharmaceutical ingredients (API) unit at Waluj in Aurangabad in Maharashtra with an investment of Rs. 95 million. The project involves setting up of manufacturing facilities to produce Lumefantrine ( 2mtpm), Propyphenazone (2 mtpm), Atenolol ( 2mtpm), Picotamide ( 1 mtpm), Acipimox ( 1 mtpm), Tenatoprazole ( 1mtpm) among other chemicals. The company will use the active pharmaceutical ingredients (API) for captive consumption for making their own bulk drug formulations.

Custom Search

Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202   Mobile : 0-97898-37940 email : ibischennai@gmail.com Privacy Policy